33
/de/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135693
178559
2
Public Timelines
FAQ Das Premium bekommen

28 Sept 2017 Jahr - FDA sent letters to IR opioid analgesic manufacturers informing them that their products that are intended to be used in the outpatient setting will be subject to the same REMS requirements as the ER/LA opioid analgesics.

Zugefügt zum Band der Zeit:

13 Nov 2018
0
0
521

Datum:

28 Sept 2017 Jahr
Jetzt
~ 8 years ago